Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 1:2024:8818934.
doi: 10.1155/2024/8818934. eCollection 2024.

White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years

Affiliations

White Matter Lesion Volumes on 3-T MRI in People With MS Who Had Followed a Diet and Lifestyle Program for More Than 10 Years

Mariaan Jaftha et al. Mult Scler Int. .

Abstract

Background: Cerebral white matter lesion (WML) formation in people with multiple sclerosis (pwMS) is linked to the death of myelin-producing oligodendrocytes. Current MS treatment strategies focus on limiting WML accumulation and disability. Using a pathology-supported genetic testing (PSGT) program, we identified specific risk factors for MS, categorized as deficiencies and aggravators. We developed a novel clinical methodology to mitigate these risk factors, including personalized lifestyle interventions and optimization of cerebral nutrients to prevent oligodendrocyte demise and promote remyelination. Objective: To conduct a pilot case-control study over a 10-year period to ascertain whether the PSGT Program can reduce or prevent WML formation in pwMS. Methods: MRI was performed at baseline as well as after an interval period of at least 10 years or longer in 22 pwMS. WML volumes were determined using Sequence Adaptive Multimodal SEGmentation (SAMSEG) software, part of FreeSurfer 7.2. Other variables included age at MRI, disease duration, disability status, and medication. Results: PwMS (n = 13) who had followed the PSGT program for more than 10 years, had significantly smaller lesion volumes (mm3) compared to pwMS who did not adhere to the program (n = 9) (4950 ± 5303 vs. 17934 ± 11139; p = 0.002). WML volumes were significantly associated (p = 0.02) with disability (EDSS) but not with age (p = 0.350), disease duration (p = 0.709), or Interferon-β treatment (p = 0.70). Conclusion: Dietary and lifestyle changes may lower the risk of developing cerebral WMLs in pwMS and potentially slow disease progression. Larger studies are required to confirm the effectiveness of such interventions in pwMS.

Keywords: MRI; SAMSEG; diet; lifestyle; multiple sclerosis; white matter lesion volumes.

PubMed Disclaimer

Conflict of interest statement

Maritha J. Kotze is a nonexecutive director and shareholder of Gknowmix (Pty) Ltd, a spin-out company of the South African Medical Research Council. Lindiwe Whati is a shareholder, and Susan J. van Rensburg is the scientific advisor at Gknowmix (Pty) Ltd. The remaining authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Demyelination and remyelination of the early MS lesion as revealed by neuropathological studies [1, 2]. Oligodendrocytes experience cell death and are unable to maintain the myelin sheath; then, activated microglia or monocyte-derived macrophages digest (scavenge) the dead oligodendrocytes and dysfunctional myelin without damaging the axons. Thereafter, oligodendrocyte precursor cells (OPCs) become the new oligodendrocytes and remyelinate the axons, restoring functionality.
Figure 2
Figure 2
Significant difference between white matter lesion volumes of pwMS (n = 13) who had followed the PSGT Program for >10 years and pwMS (n = 9) who had not, 4950 ± 5303 versus 17934 ± 11139 mm3 (p = 0.002) Hedges D = 1.53 (large effect size). N = no; Y = yes.
Figure 3
Figure 3
Resolution of white matter lesions in one of the designated pwMS who could not be scanned using 3-T MRI due to claustrophobia. MRIs in 2012 and 2014 were done in a hospital using sedation under clinical supervision by a neurologist.

Similar articles

References

    1. Barnett M. H., Prineas J. W. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Annals of Neurology . 2004;55(4):458–468. doi: 10.1002/ana.20016. - DOI - PubMed
    1. Barnett M. H., Henderson A. P., Prineas J. W. The macrophage in MS: just a scavenger after all? Pathology and pathogenesis of the acute MS lesion. Multiple Sclerosis . 2006;12(2):121–132. doi: 10.1191/135248506ms1304rr. - DOI - PubMed
    1. Prineas J., Lee S. Microglia subtypes in acute, subacute, and chronic multiple sclerosis. Journal of Neuropathology and Experimental Neurology . 2023;82(8):674–694. doi: 10.1093/jnen/nlad046. - DOI - PMC - PubMed
    1. Prineas J. W., Parratt J. D. E. Multiple sclerosis: microglia, monocytes, and macrophage-mediated demyelination. Journal of Neuropathology and Experimental Neurology . 2021;80(10):975–996. doi: 10.1093/jnen/nlab083. - DOI - PMC - PubMed
    1. Bergles D. E., Richardson W. D. Oligodendrocyte development and plasticity. Cold Spring Harbor Perspectives in Biology . 2015;8(2, article a020453) doi: 10.1101/cshperspect.a020453. - DOI - PMC - PubMed

LinkOut - more resources